Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pracinostat Food and Smoking Effect Study
NCT02058784Phase 1Completed
- Sponsor
- Helsinn
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pracinostat in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (2 arms), sponsored by Helsinn. Primary endpoint: Pharmacokinetics of pracinostat at 3 days. Started Feb 2014; status: completed.
02
Drugs
pracinostat
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02058784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058784.